Clinical Trial Update: Immunotherapy for Third Line Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating immunotherapy for third-line metastatic colorectal cancer has completed. The snippet does not include efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Mirror Biologics, Inc. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED